Status: Recruiting
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Early Feasibility Study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft in the treatment of severe or greater tricuspid regurgitation (TR).
Participants needed: 15
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Innoventric LTDUpdated: Mar 7, 2025Locations: 12
Eligibility criteria
Patient has clinically significant TR graded as severe or greater [+3]
Severe RV dysfunction defined by TAPSE, RVEF, or RVFAC. [+9]